Suppr超能文献

蜡样芽孢杆菌肽脱甲酰基酶(PDF)在无配体和放线菌素结合形式下的结晶及初步X射线晶体学分析。

Crystallization and preliminary X-ray crystallographic analysis of peptide deformylase (PDF) from Bacillus cereus in ligand-free and actinonin-bound forms.

作者信息

Park Joon Kyu, Moon Jin Ho, Kim Jae-Hong, Kim Eunice EunKyeong

机构信息

Life Sciences Division, Korea Institute of Science and Technology, Seoul 130-650, South Korea.

出版信息

Acta Crystallogr Sect F Struct Biol Cryst Commun. 2005 Jan 1;61(Pt 1):150-2. doi: 10.1107/S1744309104032440. Epub 2004 Dec 24.

Abstract

In bacteria, protein expression initiates with an N-formyl group and this needs to be removed in order to ensure proper bacterial growth. These formylation and deformylation processes are unique to eubacteria; therefore, inhibition of these would provide a novel antibacterial therapy. Deformylation is carried out by peptide deformylase (PDF). PDF from Bacillus cereus, one of the major pathogenic bacteria, was cloned into expression plasmid pET-28a (Novagen), overexpressed in Escherichia coli BL21 (DE3) and purified to high quality. Crystals have been obtained of both ligand-free PDF and PDF to which actinonin, a highly potent naturally occurring inhibitor, is bound. Both crystals belong to space group P2(1)2(1)2(1), with unit-cell parameters a = 42.72, b = 44.04, c = 85.19 A and a = 41.31, b = 44.56, c = 84.47 A, respectively. Diffraction data were collected to 1.7 A resolution for the inhibitor-free crystals and to 2.0 A resolution for the actinonin-bound crystals.

摘要

在细菌中,蛋白质表达起始于一个N-甲酰基,为确保细菌正常生长需要将其去除。这些甲酰化和去甲酰化过程是真细菌所特有的;因此,抑制这些过程将提供一种新型抗菌疗法。去甲酰化由肽脱甲酰基酶(PDF)进行。来自主要病原菌之一蜡样芽孢杆菌的PDF被克隆到表达质粒pET-28a(纽英伦公司)中,在大肠杆菌BL21(DE3)中过量表达并纯化至高质量。已获得无配体PDF以及与高效天然抑制剂放线菌素结合的PDF的晶体。两种晶体均属于空间群P2(1)2(1)2(1),其晶胞参数分别为a = 42.72,b = 44.04,c = 85.19 Å和a = 41.31,b = 44.56,c = 84.47 Å。对无抑制剂晶体收集了分辨率为1.7 Å的衍射数据,对结合放线菌素的晶体收集了分辨率为2.0 Å的衍射数据。

相似文献

1
Crystallization and preliminary X-ray crystallographic analysis of peptide deformylase (PDF) from Bacillus cereus in ligand-free and actinonin-bound forms.
Acta Crystallogr Sect F Struct Biol Cryst Commun. 2005 Jan 1;61(Pt 1):150-2. doi: 10.1107/S1744309104032440. Epub 2004 Dec 24.
2
Co-crystallization of Leptospira interrogans peptide deformylase with a potent inhibitor and molecular-replacement schemes with eight subunits in an asymmetric unit.
Acta Crystallogr D Biol Crystallogr. 2004 Jan;60(Pt 1):137-9. doi: 10.1107/s0907444903022480. Epub 2003 Dec 18.
3
Co-crystallization of Staphylococcus aureus peptide deformylase (PDF) with potent inhibitors.
Acta Crystallogr D Biol Crystallogr. 2002 Dec;58(Pt 12):2153-6. doi: 10.1107/s090744490201569x. Epub 2002 Nov 23.
4
Crystallization and preliminary X-ray crystallographic analysis of peptide deformylase from Pseudomonas aeruginosa.
Acta Crystallogr D Biol Crystallogr. 2002 Oct;58(Pt 10 Pt 2):1874-5. doi: 10.1107/s0907444902013835. Epub 2002 Sep 28.
5
Ligand-induced changes in the structure and dynamics of Escherichia coli peptide deformylase.
Biochemistry. 2009 Aug 18;48(32):7595-607. doi: 10.1021/bi900600b.
6
Protein preparation, crystallization and preliminary X-ray analysis of imidazolonepropionase from Bacillus subtilis.
Biochim Biophys Acta. 2006 Jan;1764(1):153-6. doi: 10.1016/j.bbapap.2005.08.012. Epub 2005 Sep 12.
7
Expression, crystallization and preliminary X-ray crystallographic analysis of peptide deformylase from Xanthomonas oryzae pv. oryzae.
Acta Crystallogr Sect F Struct Biol Cryst Commun. 2008 Nov 1;64(Pt 11):1031-3. doi: 10.1107/S1744309108031631. Epub 2008 Oct 28.
8
Characterization of peptide deformylase2 from B. cereus.
J Biochem Mol Biol. 2007 Nov 30;40(6):1050-7. doi: 10.5483/bmbrep.2007.40.6.1050.
9
Crystallization and preliminary crystallographic analysis of N-acetylglucosamine 6-phosphate deacetylase from Escherichia coli.
Acta Crystallogr D Biol Crystallogr. 2000 May;56(Pt 5):670-2. doi: 10.1107/s0907444900003668.
10
Actinonin, a naturally occurring antibacterial agent, is a potent deformylase inhibitor.
Biochemistry. 2000 Feb 15;39(6):1256-62. doi: 10.1021/bi992245y.

本文引用的文献

1
Processing of X-ray diffraction data collected in oscillation mode.
Methods Enzymol. 1997;276:307-26. doi: 10.1016/S0076-6879(97)76066-X.
2
Peptide deformylase: a target for novel antibiotics?
Expert Opin Ther Targets. 2001 Feb;5(1):23-40. doi: 10.1517/14728222.5.1.23.
3
4
An improved crystal form of Plasmodium falciparum peptide deformylase.
Protein Sci. 2004 Apr;13(4):1155-63. doi: 10.1110/ps.03456404. Epub 2004 Mar 9.
5
Targeting metalloenzymes: a strategy that works.
Curr Opin Pharmacol. 2003 Oct;3(5):502-7. doi: 10.1016/s1471-4892(03)00115-2.
6
Characterization of a human peptide deformylase: implications for antibacterial drug design.
Biochemistry. 2003 Aug 26;42(33):9952-8. doi: 10.1021/bi0346446.
10
Distinctive features of the two classes of eukaryotic peptide deformylases.
J Mol Biol. 2001 Dec 7;314(4):695-708. doi: 10.1006/jmbi.2001.5175.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验